Bioanalysis is a term used to describe quantitative measurement of a compound (drug) or its metabolite in biological fluids, mainly blood, plasma, serum, urine or tissue extracts. Two main components of a bioanalytical method.
The process of drug discovery and development is well understood and accepted worldwide as an essential tool in the field of bioenergy analysis. Over the past few years, a plethora of assays have been continuously developed for NCEs, including several stages of discovery and development, including important metabolites for assays. In addition, several analytical procedures are available for prescription drugs (Rx) and / or generics. The Bioanalytical Data generated in the Discovery and Preclinical Programs are the first clinical programs for a precious guide Plasma concentration-response data from these programs can be compared to those obtained in humans. Such comparisons are particularly useful in the Phase 1 study of initial dose escalation. To maximize this, we have the habit of generating PK data between each dose increase
Bioanalytical studies that have been targeted include amino acids, peptides, proteins, serum enzymes, tumor and cancer genes, carbohydrates, vitamins, catecholamines, factors, etc. With the recurrent analysis of biomolecules, many analytical techniques and instrumentation have been developed and applied in the field of medical sciences: sensors, electrophoresis, chromatography, mass spectrometry, techniques. Radio and immunochemical techniques, Hyphen techniques, Point of service instrumentation